RENAL
Timeline
10 events since 2021Filings
Financial
Establishments
202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 2 days before the deadline
2025
Weakest financial year net -€24,692 The net result drops to -€24,692, the lowest from 2021 to 2025.
Liquidity more than triples current ratio 36.00 The current ratio rises from 9.82 to 36.00. Short-term debt falls from €6,549 to €1,363.
Annual accounts 2024 filed PDFmicro format · 16 days before the deadline
2024
Back to profit net €3,576 The net result is €3,576, after one loss-making year.
Annual accounts 2023 filed PDFmicro format · 33 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 32 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 31 days before the deadline
2021
Incorporation · Resignations & appointmentsFounding capital of €506,388.53, 25,826 shares · Demerger: IMMOBILIERE DE RENAL splits off to RENAL · Founded by IMMOBILIERE DE RENAL · published on 18-01-202115 points ▸
- The capital is divided into 25,826 shares
- The operation takes effect in the accounts on 01-07-2020
- holds 2,593 shares
- holds 147 shares
- holds 143 shares
- holds 143 shares
- holds 143 shares
- holds 4,801 shares
- holds 3,915 shares
- holds 4,647 shares
- holds 4,647 shares
- holds 4,647 shares
- appointed as sole director
- Founded by IMMOBILIERE DE RENAL
- The founding capital is €506,388.53, divided into 25,826 shares
- The deed holds 59 more points.
First establishment Renal 1-2, Ouffet
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 7 January 2021, RENAL was incorporated as a private limited company by IMMOBILIERE DE RENAL and 10 private individuals, with a starting capital of €506,389.12 has served as sole director since 2021.3 Total assets went from €560,648 in 2021 to €546,204 in 2025.4